File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion

TitleFailure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
Authors
Lee, Shui ShanAnderson, Peter L.Kwan, Tsz HoLui, Grace C.Y.Chan, Denise P.C.Wong, Ngai SzeLee, Krystal C.K.Lam, Teddy T.N.
KeywordsAntiretroviral
HIV seroconversion
Pre-exposure prophylaxis
PrEP failure
Issue Date2020
Citation
International Journal of Infectious Diseases, 2020, v. 94, p. 41-43 How to Cite?
DOI: http://dx.doi.org/10.1016/j.ijid.2020.03.014
AbstractFailure of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine may occur despite perfect adherence, although this is uncommon. Failure results in breakthrough HIV infection. Delayed seroconversion associated with antiretroviral use may complicate the picture, causing uncertainties in interpreting adherence patterns for establishing the true cause of PrEP failure.
Persistent Identifierhttp://hdl.handle.net/10722/324129
ISSN
1201-9712
2021 Impact Factor: 12.074
2020 SCImago Journal Rankings: 1.278
ISI Accession Number ID
WOS:000533643700010

 

DC FieldValueLanguage
dc.contributor.authorLee, Shui Shan-
dc.contributor.authorAnderson, Peter L.-
dc.contributor.authorKwan, Tsz Ho-
dc.contributor.authorLui, Grace C.Y.-
dc.contributor.authorChan, Denise P.C.-
dc.contributor.authorWong, Ngai Sze-
dc.contributor.authorLee, Krystal C.K.-
dc.contributor.authorLam, Teddy T.N.-
dc.date.accessioned2023-01-13T03:01:42Z-
dc.date.available2023-01-13T03:01:42Z-
dc.date.issued2020-
dc.identifier.citationInternational Journal of Infectious Diseases, 2020, v. 94, p. 41-43-
dc.identifier.issn1201-9712-
dc.identifier.urihttp://hdl.handle.net/10722/324129-
dc.description.abstractFailure of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine may occur despite perfect adherence, although this is uncommon. Failure results in breakthrough HIV infection. Delayed seroconversion associated with antiretroviral use may complicate the picture, causing uncertainties in interpreting adherence patterns for establishing the true cause of PrEP failure.-
dc.languageeng-
dc.relation.ispartofInternational Journal of Infectious Diseases-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAntiretroviral-
dc.subjectHIV seroconversion-
dc.subjectPre-exposure prophylaxis-
dc.subjectPrEP failure-
dc.titleFailure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1016/j.ijid.2020.03.014-
dc.identifier.pmid32173577-
dc.identifier.scopuseid_2-s2.0-85083318514-
dc.identifier.volume94-
dc.identifier.spage41-
dc.identifier.epage43-
dc.identifier.eissn1878-3511-
dc.identifier.isiWOS:000533643700010-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats